Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 580 studies with search of: | Open Studies | United States, Utah |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
|
||||
2 | Recruiting |
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
|
||||
3 | Recruiting |
Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
|
||||
4 | Recruiting |
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
|
||||
5 | Recruiting |
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
|
||||
6 | Recruiting |
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
|
||||
7 | Recruiting |
Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases
|
||||
8 | Recruiting |
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
|
||||
9 | Recruiting |
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
|
||||
10 | Recruiting |
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
|
||||
11 | Recruiting |
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
|
||||
12 | Recruiting |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
|
||||
13 | Recruiting |
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
|
||||
14 | Recruiting |
Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
|
||||
15 | Recruiting |
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
|
||||
16 | Recruiting |
Letrozole After Tamoxifen in Treating Women With Breast Cancer
|
||||
17 | Recruiting |
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
|
||||
18 | Recruiting |
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
|
||||
19 | Recruiting |
Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
|
||||
20 | Recruiting |
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |